APO Research
Talk to an analyst

APO RESEARCH · REPORT

Addiction Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Addiction Treatment Market Outlook and Growth Opportunities 2026

22 December 2025193 pages

Choose your research edition.

Industry ResearchAddiction Treatment Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Addiction Treatment Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Addiction Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Addiction Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Addiction Treatment Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Addiction Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Addiction Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Addiction Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Addiction Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Addiction Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Addiction Treatment market include Purdue Pharma, Pfizer, GlaxoSmithKiline, Reckitt Benckiser, Orexo, Mallinckrodt, Cipla, Allergan and Alkermes, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Addiction Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Addiction Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Addiction Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Addiction Treatment market.

Addiction Treatment Segment by Company

Purdue Pharma

Pfizer

GlaxoSmithKiline

Reckitt Benckiser

Orexo

Mallinckrodt

Cipla

Allergan

Alkermes

Addiction Treatment Segment by Type

Tobacco/Nicotine Addiction Treatment

Tobacco/Nicotine Addiction Treatment

Alcohol Addiction Treatment

Other Substance Addiction Treatment

Addiction Treatment Segment by Application

Residential Treatment Center

Inpatient Treatment Center

Outpatient Treatment Center

Addiction Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Addiction Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Addiction Treatment key companies, revenue, market share, and recent developments.

3. To split the Addiction Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Addiction Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Addiction Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Addiction Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Addiction Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Addiction Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Addiction Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Addiction Treatment industry.

Chapter 3: Detailed analysis of Addiction Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Addiction Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Addiction Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Addiction Treatment Industry Trends Table 2. Addiction Treatment Industry Drivers Table 3. Addiction Treatment Industry Opportunities and Challenges Table 4. Addiction Treatment Industry Restraints Table 5. Global Addiction Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Addiction Treatment Revenue Share by Company (2021-2026) Table 7. Global Addiction Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Addiction Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Addiction Treatment Company, Product Type & Application Table 10. Global Addiction Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Addiction Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Tobacco/Nicotine Addiction Treatment Table 15. Significant Companies of Tobacco/Nicotine Addiction Treatment Table 16. Significant Companies of Alcohol Addiction Treatment Table 17. Significant Companies of Other Substance Addiction Treatment Table 18. Global Addiction Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Addiction Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Addiction Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Addiction Treatment Sales Value Share by Type (2021-2026) Table 22. Global Addiction Treatment Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Residential Treatment Center Table 24. Significant Companies of Inpatient Treatment Center Table 25. Significant Companies of Outpatient Treatment Center Table 26. Global Addiction Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Addiction Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Addiction Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Addiction Treatment Sales Value Share by Application (2021-2026) Table 30. Global Addiction Treatment Sales Value Share by Application (2027-2032) Table 31. Global Addiction Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Addiction Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Addiction Treatment Sales Value Share by Region (2021-2026) Table 34. Global Addiction Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Addiction Treatment Sales Value Share by Region (2027-2032) Table 36. Global Addiction Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Addiction Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Addiction Treatment Sales Value Market Share by Country (2021-2026) Table 39. Global Addiction Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Addiction Treatment Sales Value Market Share by Country (2027-2032) Table 41. Purdue Pharma Company Information Table 42. Purdue Pharma Business Overview Table 43. Purdue Pharma Addiction Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Purdue Pharma Addiction Treatment Product Portfolio Table 45. Purdue Pharma Recent Development Table 46. Pfizer Company Information Table 47. Pfizer Business Overview Table 48. Pfizer Addiction Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Pfizer Addiction Treatment Product Portfolio Table 50. Pfizer Recent Development Table 51. GlaxoSmithKiline Company Information Table 52. GlaxoSmithKiline Business Overview Table 53. GlaxoSmithKiline Addiction Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. GlaxoSmithKiline Addiction Treatment Product Portfolio Table 55. GlaxoSmithKiline Recent Development Table 56. Reckitt Benckiser Company Information Table 57. Reckitt Benckiser Business Overview Table 58. Reckitt Benckiser Addiction Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Reckitt Benckiser Addiction Treatment Product Portfolio Table 60. Reckitt Benckiser Recent Development Table 61. Orexo Company Information Table 62. Orexo Business Overview Table 63. Orexo Addiction Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Orexo Addiction Treatment Product Portfolio Table 65. Orexo Recent Development Table 66. Mallinckrodt Company Information Table 67. Mallinckrodt Business Overview Table 68. Mallinckrodt Addiction Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Mallinckrodt Addiction Treatment Product Portfolio Table 70. Mallinckrodt Recent Development Table 71. Cipla Company Information Table 72. Cipla Business Overview Table 73. Cipla Addiction Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Cipla Addiction Treatment Product Portfolio Table 75. Cipla Recent Development Table 76. Allergan Company Information Table 77. Allergan Business Overview Table 78. Allergan Addiction Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Allergan Addiction Treatment Product Portfolio Table 80. Allergan Recent Development Table 81. Alkermes Company Information Table 82. Alkermes Business Overview Table 83. Alkermes Addiction Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Alkermes Addiction Treatment Product Portfolio Table 85. Alkermes Recent Development Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Addiction Treatment Product Image Figure 2. Global Addiction Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Addiction Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Addiction Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Tobacco/Nicotine Addiction Treatment Image Figure 8. Tobacco/Nicotine Addiction Treatment Image Figure 9. Alcohol Addiction Treatment Image Figure 10. Other Substance Addiction Treatment Image Figure 11. Global Addiction Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Addiction Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Addiction Treatment Sales Value Share by Type (2021-2032) Figure 14. Residential Treatment Center Image Figure 15. Inpatient Treatment Center Image Figure 16. Outpatient Treatment Center Image Figure 17. Global Addiction Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Addiction Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Addiction Treatment Sales Value Share by Application (2021-2032) Figure 20. Global Addiction Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Addiction Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Addiction Treatment Sales Value (2021-2032) & (US$ Million) Figure 23. North America Addiction Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Addiction Treatment Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Addiction Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Addiction Treatment Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Addiction Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Addiction Treatment Sales Value (2021-2032) & (US$ Million) Figure 29. South America Addiction Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Addiction Treatment Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Addiction Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Addiction Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Addiction Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Addiction Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Tobacco/Nicotine Addiction Treatment
  • Tobacco/Nicotine Addiction Treatment
  • Alcohol Addiction Treatment
  • Other Substance Addiction Treatment
Applications
  • Residential Treatment Center
  • Inpatient Treatment Center
  • Outpatient Treatment Center
Companies covered
  • Purdue Pharma
  • Pfizer
  • GlaxoSmithKiline
  • Reckitt Benckiser
  • Orexo
  • Mallinckrodt
  • Cipla
  • Allergan
  • Alkermes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Addiction Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Addiction Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Addiction Treatment Market Dynamics
  1. 2.1 Addiction Treatment Industry Trends
  2. 2.2 Addiction Treatment Industry Drivers
  3. 2.3 Addiction Treatment Industry Opportunities and Challenges
  4. 2.4 Addiction Treatment Industry Restraints
3 Addiction Treatment Market by Company
  1. 3.1 Global Addiction Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Addiction Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Addiction Treatment Company Ranking (2024-2026)
  4. 3.4 Global Addiction Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Addiction Treatment Company Product Type and Application
  6. 3.6 Global Addiction Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Addiction Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Addiction Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Addiction Treatment Market by Type
  1. 4.1 Addiction Treatment Type Introduction
  2. 4.1.1 Tobacco/Nicotine Addiction Treatment
  3. 4.1.2 Tobacco/Nicotine Addiction Treatment
  4. 4.1.3 Alcohol Addiction Treatment
  5. 4.1.4 Other Substance Addiction Treatment
  6. 4.2 Global Addiction Treatment Sales Value by Type
  7. 4.2.1 Global Addiction Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Addiction Treatment Sales Value by Type (2021-2032)
  9. 4.2.3 Global Addiction Treatment Sales Value Share by Type (2021-2032)
5 Addiction Treatment Market by Application
  1. 5.1 Addiction Treatment Application Introduction
  2. 5.1.1 Residential Treatment Center
  3. 5.1.2 Inpatient Treatment Center
  4. 5.1.3 Outpatient Treatment Center
  5. 5.2 Global Addiction Treatment Sales Value by Application
  6. 5.2.1 Global Addiction Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Addiction Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global Addiction Treatment Sales Value Share by Application (2021-2032)
6 Addiction Treatment Regional Value Analysis
  1. 6.1 Global Addiction Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Addiction Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Addiction Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Addiction Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Addiction Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Addiction Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Addiction Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Addiction Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Addiction Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Addiction Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Addiction Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Addiction Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Addiction Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Addiction Treatment Sales Value Share by Country, 2025 VS 2032
7 Addiction Treatment Country-level Value Analysis
  1. 7.1 Global Addiction Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Addiction Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Addiction Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Addiction Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Addiction Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Addiction Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Addiction Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Addiction Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Addiction Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Addiction Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Addiction Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Addiction Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Addiction Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Addiction Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Addiction Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Addiction Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Addiction Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Addiction Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Addiction Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Addiction Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Addiction Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Addiction Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Addiction Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Addiction Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Addiction Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Addiction Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Addiction Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Addiction Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Addiction Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Addiction Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Addiction Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Addiction Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Addiction Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Addiction Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Addiction Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Purdue Pharma
  2. 8.1.1 Purdue Pharma Company Information
  3. 8.1.2 Purdue Pharma Business Overview
  4. 8.1.3 Purdue Pharma Addiction Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Purdue Pharma Addiction Treatment Product Portfolio
  6. 8.1.5 Purdue Pharma Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Addiction Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Addiction Treatment Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 GlaxoSmithKiline
  14. 8.3.1 GlaxoSmithKiline Company Information
  15. 8.3.2 GlaxoSmithKiline Business Overview
  16. 8.3.3 GlaxoSmithKiline Addiction Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKiline Addiction Treatment Product Portfolio
  18. 8.3.5 GlaxoSmithKiline Recent Developments
  19. 8.4 Reckitt Benckiser
  20. 8.4.1 Reckitt Benckiser Company Information
  21. 8.4.2 Reckitt Benckiser Business Overview
  22. 8.4.3 Reckitt Benckiser Addiction Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Reckitt Benckiser Addiction Treatment Product Portfolio
  24. 8.4.5 Reckitt Benckiser Recent Developments
  25. 8.5 Orexo
  26. 8.5.1 Orexo Company Information
  27. 8.5.2 Orexo Business Overview
  28. 8.5.3 Orexo Addiction Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Orexo Addiction Treatment Product Portfolio
  30. 8.5.5 Orexo Recent Developments
  31. 8.6 Mallinckrodt
  32. 8.6.1 Mallinckrodt Company Information
  33. 8.6.2 Mallinckrodt Business Overview
  34. 8.6.3 Mallinckrodt Addiction Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mallinckrodt Addiction Treatment Product Portfolio
  36. 8.6.5 Mallinckrodt Recent Developments
  37. 8.7 Cipla
  38. 8.7.1 Cipla Company Information
  39. 8.7.2 Cipla Business Overview
  40. 8.7.3 Cipla Addiction Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cipla Addiction Treatment Product Portfolio
  42. 8.7.5 Cipla Recent Developments
  43. 8.8 Allergan
  44. 8.8.1 Allergan Company Information
  45. 8.8.2 Allergan Business Overview
  46. 8.8.3 Allergan Addiction Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Allergan Addiction Treatment Product Portfolio
  48. 8.8.5 Allergan Recent Developments
  49. 8.9 Alkermes
  50. 8.9.1 Alkermes Company Information
  51. 8.9.2 Alkermes Business Overview
  52. 8.9.3 Alkermes Addiction Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Alkermes Addiction Treatment Product Portfolio
  54. 8.9.5 Alkermes Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst